Abstract

Two series of experiments were performed. In the first one experiments were carried out in Koletsky genetically hypertensive lean female rats and in the normotensive female rats of Wistar strain. Glucose intolerance was induced by oligemic brain hypoxia (4 hours of occlusion of both common carotid arteries followed by 44 hours reperfusion). Brain water content were used as a marker of brain edema. Changes in insulinemia and specific insulin binding were used as expression of regulative mechanisms participating in modification of glucose tolerance. The effect of terguride (trans-dihydro-lisuride) was tested. Brain hypoxia induced glucose intolerance in both strains of rat but brain edema was found only in the normotensive females. Both abnormalities were alleviated by terguride treatment. Basal glycaemia was not changed either by the brain hypoxia or by terguride treatment, except normotensive female where brain hypoxia induced hyperglycaemia. The second series of experiments were carried out in the normotensive females. The arrangement of experiments was the same as in first series except omission of the final glucose tolerance test. Brain hypoxia causes increase in brain water content. The mentioned elevation of brain water content was alleviated by terguride treatment. Insulin binding to erythrocytes was not influenced by brain hypoxia. Terguride treatment shows decrease of insulin binding to erythrocytes. Brain hypoxia elevates insulinemia which was not alleviated by terguride treatment.

Highlights

  • In our previous paper (2) we documented the abnormalities of glucose tolerance in the obese genetically hypertensive Koletsky (SHR/N-cp) rats as well as in their lean siblings

  • These genetically based abnormalities of the glucose tolerance were accompanied by alterations of insulin binding to erythrocytes and hepatocytes (8)

  • The mentioned drug induced alleviation of glucose intolerance was accompanied by decrease of insulinemia (4) and by increase of insulin binding to erythrocytes (4)

Read more

Summary

Introduction

In our previous paper (2) we documented the abnormalities of glucose tolerance in the obese genetically hypertensive Koletsky (SHR/N-cp) rats as well as in their lean siblings. These genetically based abnormalities of the glucose tolerance were accompanied by alterations of insulin binding to erythrocytes and hepatocytes (8). The study of insulin binding showed that long lasting terguride treatment elevated insulin binding to erthrocytes (4). These finding suggested a possible causal relationship between alleviation of glucose intolerance and the elevation of of insulin binding to erythrocytes

Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.